|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09886 DINGDANG HEALTH
Nominal 
0.900 +0.020 (+2.273%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 136,819 | (11,352) | (5,237) | (237,871) |
| Net Cash from / (used in) Investing Activities | -- | (801,193) | 156,959 | 104,324 | (353,416) |
| Net Cash from / (used in) Financing Activities | -- | (112,078) | (121,370) | (130,537) | 232,896 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (776,452) | 24,237 | (31,450) | (358,391) |
| Cash & Cash Equivalents at beginning of period | -- | 1,217,954 | 1,185,898 | 1,210,949 | 1,552,994 |
| Effect of Foreign Exchange Rate Changes | -- | (12,179) | 7,819 | 6,399 | 16,346 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 429,323 | 1,217,954 | 1,185,898 | 1,210,949 |
| Remarks: | Real time quote last updated: 03/09/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -64,371 |
| %Change | 24.579% |
| EPS / (LPS) | RMB -0.050 |
| NBV Per Share (¥) | RMB 1.216 |